Question 1

What is arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum?

Accepted Answer

Arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum is a complex condition that primarily affects the musculoskeletal and central nervous systems. It is caused by pathogenic variants in the SCYL2 gene, which play a role in normal neurological and developmental processes. This condition presents early in life with multiple abnormalities, and its exact prevalence is not well established. Affected individuals experience a constellation of features that include both motor and cognitive challenges, underscoring the multifaceted impact of the disorder.

Question 2

What are the symptoms of arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum?

Accepted Answer

The clinical presentation of this condition spans several organ systems. Neurologically, individuals exhibit global developmental delay, seizures, and features that impact cognitive function, all of which underscore the involvement of the brain. Craniofacially, characteristic features such as a prominent forehead, bulbous nose, depressed nasal bridge, narrow mouth, and micrognathia are consistently observed. Musculoskeletal findings are also striking, with arthrogryposis multiplex congenita evident along with hand clenching, rocker bottom feet, and decreased fetal movement noted early in life. Additionally, signs such as agenesis of the corpus callosum, optic atrophy, spasticity, and other features like cryptorchidism and feeding difficulties reinforce the multi-system nature of the disorder. Not all individuals experience every feature, and severity varies considerably.

Question 3

What causes arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum?

Accepted Answer

This condition is caused by pathogenic variants in the SCYL2 gene. The SCYL2 protein is believed to play an important role in normal cell function and neurological development, and its disruption leads to the multisystem abnormalities seen in affected individuals. Arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum follows an autosomal recessive inheritance pattern, meaning that an affected individual has inherited one altered copy of SCYL2 from each parent. As a result, both parents are typically carriers, and there is an approximate 25% chance of recurrence with each pregnancy, making genetic counseling a valuable resource for affected families. Associated genes include SCYL2.

Question 4

How is arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum inherited?

Accepted Answer

arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How is arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum diagnosed?

Accepted Answer

The diagnosis of this condition is based on a combination of detailed clinical evaluation and molecular genetic testing. Affected individuals are identified by their characteristic clinical features, including distinctive facial, musculoskeletal, and neurological findings. Confirmation is achieved through molecular genetic testing that identifies pathogenic variants in the SCYL2 gene, which helps distinguish this condition from others with overlapping symptoms. Given the complexity of the presentation, comprehensive clinical assessment remains a critical component of the diagnostic process.

Question 6

Are there treatments for arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum?

Accepted Answer

Currently, management focuses on supportive care and symptom relief since no FDA-approved or foundational therapies have been established for this condition. Treatment is tailored to the individual and typically involves a multidisciplinary team to address the range of neurological, musculoskeletal, and other systemic challenges. Regular surveillance is an essential part of long-term care, helping to identify potential complications early and guide timely interventions. Genetic counseling is recommended to help families understand the condition, inheritance patterns, and available support options, ensuring that management strategies are optimized for each individual’s needs.

Question 7

What are the potential complications of arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum?

Accepted Answer

Individuals with arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum may face several complications due to the involvement of multiple systems. These can include seizures, cognitive delays, and musculoskeletal issues like joint stiffness. Regular monitoring is important to catch any potential complications early and to provide appropriate interventions.

Question 8

How does arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum affect daily life?

Accepted Answer

Daily life for individuals with arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum can be quite challenging. They may require assistance with mobility and daily activities due to muscle stiffness and developmental delays. Supportive care and a tailored approach from a multidisciplinary team can help improve their quality of life.

Question 9

What is the prognosis for someone with arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum?

Accepted Answer

The prognosis for individuals with arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum varies widely. While many face significant challenges, some can achieve developmental and functional milestones with appropriate care. Outcomes can improve over time as treatment strategies evolve and support systems are put in place.

Question 10

What specialists should families consult for arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum?

Accepted Answer

Families dealing with arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum should consult a team of specialists. This may include neurologists, orthopedic surgeons, and developmental pediatricians. Genetic counselors can also provide valuable support in understanding the condition and its implications for family planning.

Organ System	Phenotype Count	Example Features
Brain and nerves	4	Seizure, Global developmental delay, Depressed nasal bridge

Kisho

arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

OMIM

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Explore clinical features

Recent Publications

arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

OMIM

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum?

What are the symptoms of arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum?

What causes arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum?

How is arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum inherited?

How is arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum diagnosed?

Are there treatments for arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum?

What are the potential complications of arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum?

How does arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum affect daily life?

What is the prognosis for someone with arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum?

What specialists should families consult for arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum?

Explore clinical features

Recent Publications